Form 4: Imunon Director Donald P. Braun Acquires Options to Purchase 3,500 Shares

Director Donald P. Braun acquired options to purchase 3,500 shares of Imunon, Inc. common stock at an exercise price of $1.22 on June 12, 2024.

Summary

• On June 12, 2024, Donald P. Braun, a director of Imunon, Inc., acquired options to purchase 3,500 shares of Imunon common stock.
• The exercise price of these options is $1.22 per share.
• The options vest in three tranches: 1/2 on the grant date, 1/4 on the one-year anniversary, and 1/4 on the two-year anniversary of the grant date.
• The options expire on June 12, 2034.
• Following this transaction, Braun directly owns 23,430 shares of Imunon common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of option grants to a director, which is a common practice. It doesn't inherently indicate positive or negative sentiment, but rather provides transparency.

Positives

• The acquisition of options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide investors with insights into the actions of company directors and officers.

Comparison to Industry Standards

• Option grants to directors are a common form of compensation in publicly traded companies, aligning their interests with those of shareholders.
• The vesting schedule of the options (50% immediately, 25% after one year, and 25% after two years) is a fairly standard vesting arrangement.

Stakeholder Impact

• The acquisition of options by a director could be perceived positively by shareholders, as it aligns the director's interests with the company's success.

Key Dates

Keywords

Imunon, Director, Options, Form 4, Beneficial Ownership, IMNN, Stock Options, Securities